Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,810 | 82,629 | 71,976 | 69,663 | 285,781 |
| Marketable Securities | 204,637 | 243,904 | 235,328 | 268,200 | 73,672 |
| TOTAL | $296,458 | $334,956 | $313,750 | $341,528 | $363,869 |
| Non-Current Assets | |||||
| PPE Net | 6,359 | 6,190 | 6,356 | 2,360 | 350 |
| Other Non-Current Assets | 5,320 | 5,013 | 1,859 | 3,213 | 910 |
| TOTAL | $11,679 | $11,203 | $8,215 | $5,573 | $1,260 |
| Total Assets | $308,137 | $346,159 | $321,965 | $347,101 | $365,129 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,338 | 6,890 | 10,918 | 4,668 | 561 |
| Accrued Expenses | 19,179 | 28,618 | 31,418 | 23,353 | 22,583 |
| Other current liabilities | 165 | N/A | 218 | N/A | N/A |
| TOTAL | $30,178 | $36,892 | $42,554 | $28,021 | $23,144 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,762 | 2,748 | 144 | 167 | 186 |
| TOTAL | $2,762 | $2,748 | $144 | $167 | $186 |
| Total Liabilities | $32,940 | $39,640 | $42,698 | $28,188 | $23,330 |
| Shareholders' Equity | |||||
| Common Shares | 15 | 15 | 13 | 13 | 13 |
| Retained earnings | -297,237 | -260,046 | -194,225 | -151,645 | -127,239 |
| Other shareholders' equity | 101 | 8 | -4 | -55 | 7 |
| TOTAL | $275,197 | $306,519 | $279,267 | $318,913 | $341,799 |
| Total Liabilities And Equity | $308,137 | $346,159 | $321,965 | $347,101 | $365,129 |